Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00210132Phase 2Completed
Phase 2, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Institut Bergonié. Primary endpoint: Proportion of Patients With Major Post-operative Pain at Mobilization at 48 hours. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00210132.